Miscellaneous
Max Reiboldt and Aimee Greeter join Mark to discuss private equity deals for healthcare entities and how to approach a healthcare transaction strategically. Max, Aimee, and Mark consider how the governance of the deal and non-economic considerations during the due diligence period will affect the daily life of the providers involved. Contact Information Subscribe to our feed in Apple Podcasts, Google Podcasts, Spotify, or your preferred podcast provider. Like what you hear? Leave a review! Not there? Let us know! We welcome all feedback from our listeners. Please submit questions on any of the topics we discuss or about issues that interest you. You can also recommend topics for future episodes. Email us: feedback@cokergroup.com Connect with us on LinkedIn: Coker Group Company Page Follow us on Twitter: @cokergroup Follow us on Instagram: @cokergroup Episode Synopsis Why do so many transactions focus heavily on economic terms? The economics of any deal, especially the more attractive private equity deals, only affect one day of the providers involved within the deal. There are numerous non-economic factors that will continue to affect every day of the providers involved for years to come. Max, Aimee, and Mark discuss the strategic, non-economic terms that should receive equal consideration before finalizing any healthcare transaction. Extras Blog: Strategic Variables in Private Equity Transactions Podcast: Episode 51: Forming a Management Services Organization Podcast: Episode 34: Private Equity: The Next Stage in Physician Practice Transactions Article: The Private Equity Model for Medical Group Transactions